final overall survival (os) data from flaura trial
Published 4 years ago • 1K plays • Length 2:06Download video MP4
Download video MP3
Similar videos
-
4:22
advanced-stage nsclc: overall survival data from flaura
-
6:20
asco 2023 highlights on adjuvant osimertinib in resected egfr mutated nsclc: the adaura trial
-
8:44
flaura final analysis: osimertinib for first-line egfrm nsclc
-
7:00
flaura trial: impact of os data in advanced nsclc
-
2:20
adjuvant osimertinib in resected egfrm nsclc: the os data from the adaura trial
-
1:50
researcher comment: positive os data for osimertinib in flaura trial | suresh ramalingam
-
6:44
overall survival (os) results of the phase iii monaleesa-3 trial
-
11:20
the oncology brothers discuss adaura trial findings
-
2:39
a look at overall survival data in cancer clinical trials
-
5:42
osimertinib and the flaura trial
-
5:18
expert video report on amivantamab in combination therapy for 1l treatment in egfrm, advanced nsclc
-
6:08
flaura study: a new standard of care for patients with egfr mutated nsclc
-
25:59
final overall survival results from the phase 3 solo2 trial for ovarian cancer
-
4:17
highlights on amivantamab after progression on osimertinib in egfr-mutated nsclc: mariposa-2
-
1:15
eagerly anticipated results of the flaura trial
-
2:13
overall-survival analysis of adaura: osimertinib in resected egfrm stage ib-iiia nsclc
-
1:36
comment: front-line osimertinib significantly lengthens overall survival in egfr-mutation positi...
-
5:06
front-line osimertinib significantly lengthens overall survival in egfr-mutation positive nsclc
-
1:24
suresh ramalingam, md, fasco, shares results from the flaura trial presented at esmo 2019